LIFEVANTAGE CORP Dividends, Cash
LIFEVANTAGE CORP (LFVN) reported Dividends, Cash of $2.34 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCash · last filed 2026-08-27
- LIFEVANTAGE CORP dividends, cash for the quarter ending 2026-06-30 was $625.00K.
- LIFEVANTAGE CORP dividends, cash for the quarter ending 2026-03-31 was $572.00K, a 13.72% increase year-over-year.
- LIFEVANTAGE CORP dividends, cash for the quarter ending 2025-12-31 was $576.00K, a 14.74% increase year-over-year.
- LIFEVANTAGE CORP dividends, cash for the quarter ending 2025-09-30 was $571.00K, a 14.20% increase year-over-year.
- LIFEVANTAGE CORP dividends, cash for fiscal 2026 was $2.34M, a 13.40% increase from fiscal 2025.
- LIFEVANTAGE CORP dividends, cash for fiscal 2025 was $2.07M, a 70.22% decline from fiscal 2024.
- LIFEVANTAGE CORP dividends, cash for fiscal 2024 was $6.94M, a 337.58% increase from fiscal 2023.
- LIFEVANTAGE CORP dividends, cash for fiscal 2023 was $1.59M, a 319.58% increase from fiscal 2022.
| Period end | Dividends, Cash 3 month | Dividends, Cash 6 month | Dividends, Cash 9 month | Dividends, Cash 12 month |
|---|---|---|---|---|
| 2026-06-30 | $625.00K derived: 10-K 12 month − 3 quarters · filed 2026-08-27 | $1.20M derived: sum of 2 quarters · filed 2026-08-27 | $1.77M derived: sum of 3 quarters · filed 2026-08-27 | $2.34M 10-K · filed 2026-08-27 |
| 2026-03-31 | $572.00K 10-Q · filed 2026-05-06 | $1.15M derived: sum of 2 quarters · filed 2026-05-06 | $1.72M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2025-12-31 | $576.00K 10-Q · filed 2026-05-06 | $1.15M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2025-09-30 | $571.00K 10-Q · filed 2026-05-06 | |||
| 2025-06-30 | $2.07M 10-K · filed 2026-08-27 | |||
| 2025-03-31 | $503.00K 10-Q · filed 2026-05-06 | $1.00M derived: sum of 2 quarters · filed 2026-05-06 | $1.50M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $502.00K 10-Q · filed 2026-05-06 | $1.00M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2024-09-30 | $500.00K 10-Q · filed 2026-05-06 | |||
| 2024-06-30 | $6.94M 10-K · filed 2025-09-04 | |||
| 2024-03-31 | $448.00K 10-Q · filed 2025-05-06 | $903.00K derived: sum of 2 quarters · filed 2025-05-06 | $6.44M derived: sum of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | $455.00K 10-Q · filed 2025-05-06 | $5.99M derived: sum of 2 quarters · filed 2025-05-06 | ||
| 2023-09-30 | $5.53M 10-Q · filed 2025-05-06 | |||
| 2023-06-30 | $1.59M 10-K · filed 2024-08-28 | |||
| 2023-03-31 | $383.00K 10-Q · filed 2023-05-04 | $764.00K derived: sum of 2 quarters · filed 2024-05-02 | $1.14M derived: sum of 3 quarters · filed 2024-05-02 | |
| 2022-12-31 | $381.00K 10-Q · filed 2024-05-02 | $758.00K derived: sum of 2 quarters · filed 2024-05-02 | ||
| 2022-09-30 | $377.00K 10-Q · filed 2024-05-02 | |||
| 2022-06-30 | $378.00K 10-K · filed 2023-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |